• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去细胞化方法在支架生产中的应用:优点、缺点、生物安全性及改进

Application of decellularization methods for scaffold production: advantages, disadvantages, biosafety and modifications.

作者信息

Shevchuk O I, Korcheva V V, Moskalenko N S, Kyryk V M, Kot K V, Krasnienkov D S

机构信息

D.F. Chebotarev Institute of Gerontology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.

Biology, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine.

出版信息

Front Bioeng Biotechnol. 2025 Jun 18;13:1621641. doi: 10.3389/fbioe.2025.1621641. eCollection 2025.

DOI:10.3389/fbioe.2025.1621641
PMID:40606910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12213722/
Abstract

The development of efficient, biocompatible scaffolds is an actual challenge in tissue engineering. Scaffolds derived from animal sources offer promising structural and biochemical properties but require thorough decellularization to minimize immunogenicity and maintain extracellular matrix integrity. Effective decellularization requires a synergistic combination of methods to ensure complete removal of immunogenic cellular components while preserving critical extracellular matrix elements such as glycosaminoglycans, collagens, and growth factors. This review covers the application of some decellularization methods (physical, chemical) in scaffold production, highlighting their respective advantages, limitations, and biosafety considerations. Moreover, the importance of scaffold sterilization: both physical techniques like gamma irradiation and chemical agents-are mentioned for their efficacy and cytotoxic risks. Furthermore, scaffold modifications, particularly recellularization strategies, are discussed as key enhancements to improve biocompatibility and functional integration. Overall, the selection and optimization of decellularization protocols are crucial for the safe and effective clinical implementation of bioengineered scaffolds.

摘要

开发高效、生物相容的支架是组织工程领域当前面临的一项挑战。来自动物源的支架具有良好的结构和生化特性,但需要进行彻底的脱细胞处理,以尽量减少免疫原性并维持细胞外基质的完整性。有效的脱细胞处理需要多种方法协同组合,以确保在保留关键细胞外基质成分(如糖胺聚糖、胶原蛋白和生长因子)的同时,完全去除免疫原性细胞成分。本综述涵盖了一些脱细胞处理方法(物理、化学)在支架生产中的应用,突出了它们各自的优点、局限性和生物安全性考量。此外,还提到了支架灭菌的重要性:包括γ射线辐照等物理技术和化学试剂,阐述了它们的功效和细胞毒性风险。此外,还讨论了支架修饰,特别是再细胞化策略,作为改善生物相容性和功能整合的关键增强措施。总体而言,脱细胞处理方案的选择和优化对于生物工程支架安全有效的临床应用至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fce/12213722/126fc5a3df28/fbioe-13-1621641-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fce/12213722/818cdf91c012/fbioe-13-1621641-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fce/12213722/566dd180ecab/fbioe-13-1621641-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fce/12213722/126fc5a3df28/fbioe-13-1621641-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fce/12213722/818cdf91c012/fbioe-13-1621641-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fce/12213722/566dd180ecab/fbioe-13-1621641-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fce/12213722/126fc5a3df28/fbioe-13-1621641-g003.jpg

相似文献

1
Application of decellularization methods for scaffold production: advantages, disadvantages, biosafety and modifications.去细胞化方法在支架生产中的应用:优点、缺点、生物安全性及改进
Front Bioeng Biotechnol. 2025 Jun 18;13:1621641. doi: 10.3389/fbioe.2025.1621641. eCollection 2025.
2
Engineering Vascularized Composite Allografts Using Natural Scaffolds: A Systematic Review.利用天然支架构建工程化血管化组织同种异体移植物:系统评价。
Tissue Eng Part B Rev. 2022 Jun;28(3):677-693. doi: 10.1089/ten.TEB.2021.0102. Epub 2021 Oct 22.
3
[Liver engineering as a new source of donor organs : A systematic review].[肝脏工程作为供体器官的新来源:一项系统综述]
Chirurg. 2016 Jun;87(6):504-13. doi: 10.1007/s00104-015-0015-y.
4
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
5
Greener Decellularization of Porcine Auricular Cartilage Using Supercritical Technology and Different Pretreatments for Application in Tissue Engineering.利用超临界技术及不同预处理方法实现猪耳廓软骨的绿色脱细胞化用于组织工程
ACS Biomater Sci Eng. 2025 Jun 19. doi: 10.1021/acsbiomaterials.4c02155.
6
Combinatorial Decellularization as a Better Approach to Porcine Liver Extracellular Matrix Scaffold Fabrication With Preserved Bioactivity: A Comparative Evaluation.组合去细胞化作为一种制备具有保留生物活性的猪肝细胞外基质支架的更好方法:一项比较评估
Xenotransplantation. 2025 Mar-Apr;32(2):e70031. doi: 10.1111/xen.70031.
7
Computational Fluid Dynamics Modeling of Material Transport Through Triply Periodic Minimal Surface Scaffolds for Bone Tissue Engineering.用于骨组织工程的通过三重周期最小表面支架的物质传输的计算流体动力学建模
J Biomech Eng. 2025 Mar 1;147(3). doi: 10.1115/1.4067575.
8
Native and decellularized porcine vena cava: Biomechanical and microstructural comparison.天然及去细胞猪腔静脉:生物力学与微观结构比较。
Acta Biomater. 2025 May 31. doi: 10.1016/j.actbio.2025.05.071.
9
Combinatorial Decellularization as a Better Approach to Porcine Liver Extracellular Matrix Scaffold Fabrication With Preserved Bioactivity: A Comparative Evaluation.组合去细胞化作为一种制备具有保留生物活性的猪肝细胞外基质支架的更好方法:一项比较评估。
Xenotransplantation. 2025 Jan-Feb;32(1):e70025. doi: 10.1111/xen.70025.
10
Biohybrid microstructured hydrogels obtained via in situ extracellular matrix deposition and decellularization using supercritical CO2.通过原位细胞外基质沉积和使用超临界二氧化碳进行脱细胞处理获得的生物杂交微结构水凝胶。
Biofabrication. 2025 Jul 3. doi: 10.1088/1758-5090/adebb4.

本文引用的文献

1
Biocompatibility and Bone Regeneration by Shape Memory Polymer Scaffolds.形状记忆聚合物支架的生物相容性与骨再生
J Biomed Mater Res A. 2025 Jan;113(1):e37806. doi: 10.1002/jbm.a.37806. Epub 2024 Oct 15.
2
Two Decades of Advances and Limitations in Organ Recellularization.器官再细胞化二十年的进展与局限
Curr Issues Mol Biol. 2024 Aug 22;46(8):9179-9214. doi: 10.3390/cimb46080543.
3
Research progress of vascularization strategies of tissue-engineered bone.组织工程骨血管化策略的研究进展
Front Bioeng Biotechnol. 2024 Jan 19;11:1291969. doi: 10.3389/fbioe.2023.1291969. eCollection 2023.
4
biocompatibility testing of nanoparticle-functionalized alginate-chitosan scaffolds for tissue engineering applications.用于组织工程应用的纳米颗粒功能化藻酸盐-壳聚糖支架的生物相容性测试
Front Bioeng Biotechnol. 2023 Nov 23;11:1295626. doi: 10.3389/fbioe.2023.1295626. eCollection 2023.
5
Physical processing for decellularized nerve xenograft in peripheral nerve regeneration.用于周围神经再生的去细胞神经异种移植物的物理处理
Front Bioeng Biotechnol. 2023 May 30;11:1217067. doi: 10.3389/fbioe.2023.1217067. eCollection 2023.
6
Investigation of the In Vitro and In Vivo Biocompatibility of a Three-Dimensional Printed Thermoplastic Polyurethane/Polylactic Acid Blend for the Development of Tracheal Scaffolds.用于气管支架开发的三维打印热塑性聚氨酯/聚乳酸共混物的体外和体内生物相容性研究
Bioengineering (Basel). 2023 Mar 23;10(4):394. doi: 10.3390/bioengineering10040394.
7
Preparation and Use of Decellularized Extracellular Matrix for Tissue Engineering.用于组织工程的脱细胞细胞外基质的制备与应用
J Funct Biomater. 2022 Nov 14;13(4):240. doi: 10.3390/jfb13040240.
8
Nanoparticles derived from naturally occurring metal chelators for theranostic applications.源自天然金属螯合剂的纳米颗粒在治疗诊断中的应用。
Adv Drug Deliv Rev. 2022 Dec;191:114620. doi: 10.1016/j.addr.2022.114620. Epub 2022 Nov 13.
9
Chitosan-based scaffolds as drug delivery systems in bone tissue engineering.壳聚糖基支架作为骨组织工程中的药物传递系统。
Int J Biol Macromol. 2022 Dec 1;222(Pt A):132-153. doi: 10.1016/j.ijbiomac.2022.09.058. Epub 2022 Sep 13.
10
Biocompatibility Assessment of Two Commercial Bone Xenografts by In Vitro and In Vivo Methods.通过体外和体内方法对两种商用骨异种移植物进行生物相容性评估。
Polymers (Basel). 2022 Jun 30;14(13):2672. doi: 10.3390/polym14132672.